Lower-risk Myelodysplastic Syndromes: Data Updates and Evolving Treatment Paradigms in the Frontline Setting - Episode 4
Ralph Boccia, MD, FACP, shares his clinical experience using luspatercept to treat patient with lower-risk MDS.